Acute coronary embolism without valve thrombosis in a patient with a prosthetic mitral valve - Successful percutaneous coronary intervention: A case report

Heart Surgery Forum

Volumn 10, Issue 3, 2007, Pages 136-138

  Yazici, Mehmet ^a   Kayrak, Mehmet ^a   Turan, Yasar ^a   Koc, Fatih ^a   Ulgen, Mehmet S ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; GLYCERYL TRINITRATE; HEPARIN; SODIUM CHLORIDE; WARFARIN;

ADULT; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CORONARY STENT; EMBOLISM; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MITRAL VALVE PROSTHESIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; THROMBOSIS; THROMBOSIS PREVENTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSTHORACIC ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; HEART VALVE PROSTHESIS; MITRAL VALVE; STENT; THROMBOEMBOLISM;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MITRAL VALVE; STENTS; THROMBOEMBOLISM;

EID: 34250888688     PISSN: 10983511     EISSN: None     Source Type: Journal    
DOI: 10.1532/HSF98.20071011     Document Type: Article

References (12)

1. Aslam MS, Sanghi V, Hersh S, et al. 2002. Coronary artery saddle embolus and myocardial infarction in a patient with prosthetic mitral valve. Cathet Cardiovasc Interv 57:367-70.
2. Burchart E, Payne N, Li H, et al. 2002. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 123:715-22.
3. Charles RG, Epstein EJ. 1983. Diagnosis of coronary embolism: a review. J R Soc Med 10:863-8.
4. EPIC Investigators. 1994. Use of monoclonal antibody direct against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330:956-61.
5. Larsen AI, Galbraith PD, Ghali WA, et al. 2005. Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 95:261-3.
6. Lefkovits J, Ivanhoe RJ, Califf RM, et al. 1996. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 77:1045-51.
7. Marti V, Romeo I, Garcia J, et al. 2000. Combined therapeutic strategy for multiple coronary thromboemboli. Cathet Cardiovasc Diagn 50:343-5.
8. Mirza A. 2003. Myocardial infarction resulting from nonatherosclerotic coronary artery diseases. Am J Emerg Med 21:578-84.
9. Prizel KR, Hutchins GM, Bulkey BH. 1978. Coronary artery embolism and myocardial infarction. Ann Intern Med 88:155-61.
10. Quinn EG, Fergusson DJ. 1998. Coronary embolism following aortic and mitral valve replacement: successful management with abciximab and urokinase. Cathet Cardiovasc Diagn 43:457-9.
11. Wegner NK, Bauer S. 1958. Coronary embolism review of literature and presentation of fifteen cases. Am J Med 25:549-57.
12. Zijlstra F, de Boer MJ, Hoorntje JC, et al. 1993. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328:680-4.